Xenotransplantation Market Analysis

Xenotransplantation Market Analysis

To get key market trends

  Download Free Sample

The xenotransplantation market by product type is segregated into organ preservation solution, transplant diagnostics, xeno product and others. The xeno product segment is further classified into organ, cell, and tissue. The transplant diagnostics segment garnered more than USD 5.4 billion revenue size in the year 2022. Growing chronic diseases burden worldwide leads to surge in the number of organ failure cases. Further, ongoing advancements in diagnostic technologies such as human leukocyte antigen (HLA) typing, non-human leukocyte antigen (nHLA) typing and donor-derived cell-free DNA (dd-cfDNA) testing among others to improve the accuracy, sensitivity, and specificity of detection, facilitating early diagnosis and intervention in the xenotransplantation. Moreover, growing usage of point-of-care testing (POCT) that offers numerous advantages of rapid results, portability, and ease of use and enable real-time monitoring of graft function, rejection, or infectious complications in xenotransplantation.
 

On the basis of application, the xenotransplantation market is classified into kidney, heart, lungs, liver, and others. The kidney segment accounted for over 36% market share in the year 2022. The shortage of human kidneys for transplantation is a major factor driving industry development. The demand for kidney transplantation far exceeds the available supply, leading to long waiting lists and high mortality rates as xenotransplantation offers the possibility of utilizing pig kidneys or other non-human sources to overcome the shortage and provide more options for patients in need of kidney transplantation.
 

Based on end-use, the xenotransplantation market is subdivided into transplant centers, hospitals and others. The transplant centers segment is predicted to witness considerable growth at 8.9% CAGR by 2023. High availability of expertise with experience in organ transplantation, including xenotransplantation coupled with increasing transplant procedures among settings is anticipated to positively influence the industry gains. Additionally, transplant centers with track record of successful patient outcomes, comprehensive multidisciplinary teams, and specialized infrastructure for transplantation procedures. Growing integration of advanced technologies such as utilization of telemedicine, remote monitoring, and digital health platforms to enhance communication, remote patient management, and real-time data analysis in the context of xenotransplantation.
 

U.S. xenotransplantation market accounted for USD 7 billion revenue size in 2022. Growing prevalence of chronic diseases such as end-stage renal disease, heart failure, and liver failure in the U.S. is predicted to positively influence the industry expansion.  Additionally, shortage of organs for transplantation is another factor increasing demand for xenotransplantation. Further, high investment in research and development activities, government initiatives and favourable regulatory policies will boost novel innovations and advancements in the xenotransplantation.